700-Patient study seeks key clues to muscle disease
NCT ID NCT03981575
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is following 700 adults with myotonic dystrophy type 1 (DM1) over two years. Researchers are measuring walking speed, lung function, and muscle tissue changes to find reliable markers of disease progression. The goal is to improve future clinical trials by better understanding how DM1 behaves over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could provide the tools needed to design better treatments for myotonic dystrophy type 1.
- What could go wrong
- This is an observational study, not a treatment trial. It may not directly benefit participants and results depend on consistent data collection over 24 months.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DM1 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centro Clinico NeMO
COMPLETEDMilan, Italy
-
Friedrich Baur Institute, Ludwig-Maximilians-Universität München
RECRUITINGMünchen, Germany
-
Houston Methodist Neurological Institute
RECRUITINGHouston, Texas, 77030, United States
-
Kansas University Medical Center
RECRUITINGKansas City, Kansas, 66160, United States
-
Ohio State University
RECRUITINGColumbus, Ohio, 43210, United States
-
Radboud University Medical Center
RECRUITINGNijmegen, Netherlands
-
St. George's, University of London
RECRUITINGLondon, United Kingdom
-
University College London
RECRUITINGLondon, United Kingdom
-
University of Auckland
RECRUITINGAuckland, New Zealand
-
University of California, Los Angeles
RECRUITINGLos Angeles, California, 90095, United States
-
University of California, San Diego
RECRUITINGLa Jolla, California, 92703, United States
-
University of Colorado - Denver
RECRUITINGDenver, Colorado, 80204, United States
-
University of Florida
RECRUITINGGainesville, Florida, 32611, United States
-
University of Iowa
RECRUITINGIowa City, Iowa, 52242, United States
-
University of Rochester
RECRUITINGRochester, New York, 14642, United States
-
Université de Sherbrooke
ACTIVE_NOT_RECRUITINGQuébec, Canada
-
Virginia Commonwealth University
RECRUITINGRichmond, Virginia, 23298, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can watching the course of myotonic dystrophy unlock better care?
- Scientists hunt for biomarkers to unlock DM1 treatments
- Brain scans reveal diabetes link to cognitive decline in rare disease
- No travel needed: largest Home-Based study of myotonic dystrophy launches
- New drug DYNE-101 aims to ease muscle symptoms in DM1
- New drug AOC 1001 tested for rare muscle disease